Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Operator Continue reading
motleyfoolusx:nvcr
Shares of Novocure (NASDAQ: NVCR) jumped 18.3% this week, according to data from S&P Global Market Intelligence, after the company announced encouraging results from a phase 3 study of its Tumor Treating Fields (TTFields) therapy for treating brain metastases from non-small-cell lung cancer. In a press ...
motleyfoolusx:nvcr
Shares of Novocure (NASDAQ: NVCR) were jumping 6.3% higher as of 11:15 a.m. ET on Thursday after rising as much as 9.2% earlier in the day. The nice gain came after the company announced results from a phase 3 study evaluating its Tumor Treating Fields (TTFields) therapy in treating patients with brain ...
motleyfoolusx:nvcr
